Personal CFO Solutions’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
16,506
-5,496
| -25% | -$384K | 0.21% | 92 |
|
|
2025
Q1 | $1.62M | Buy |
22,002
+704
| +3% | +$51.7K | 0.33% | 61 |
|
|
2024
Q4 | $1.4M | Buy |
21,298
+210
| +1% | +$13.8K | 0.27% | 68 |
|
|
2024
Q3 | $1.64M | Buy |
21,088
+42
| +0.2% | +$3.27K | 0.23% | 81 |
|
|
2024
Q2 | $1.64M | Buy |
21,046
+5,813
| +38% | +$453K | 0.25% | 74 |
|
|
2024
Q1 | $1.03M | Buy |
15,233
+948
| +7% | +$64.2K | 0.16% | 121 |
|
|
2023
Q4 | $962K | Sell |
14,285
-340
| -2% | -$22.9K | 0.17% | 124 |
|
|
2023
Q3 | $990K | Sell |
14,625
-1,818
| -11% | -$123K | 0.2% | 102 |
|
|
2023
Q2 | $1.18M | Sell |
16,443
-387
| -2% | -$27.7K | 0.24% | 83 |
|
|
2023
Q1 | $1.17M | Buy |
16,830
+1,425
| +9% | +$98.9K | 0.24% | 80 |
|
|
2022
Q4 | $1.04M | Sell |
15,405
-1,194
| -7% | -$81K | 0.22% | 85 |
|
|
2022
Q3 | $910K | Buy |
+16,599
| New | +$910K | 0.23% | 80 |
|
|
2021
Q1 | – | Sell |
-4,602
| Closed | -$230K | – | 409 |
|
|
2020
Q4 | $230K | Buy |
4,602
+142
| +3% | +$7.1K | 0.06% | 318 |
|
|
2020
Q3 | $0 | Buy |
4,460
+148
| +3% | – | ﹤0.01% | 150 |
|
|
2020
Q2 | $228K | Buy |
+4,312
| New | +$228K | 0.07% | 258 |
|